Summary & Overview
HCPCS J7333: Hyaluronan (visco-3) for Intra-articular Injection, Per Dose
HCPCS Level II code J7333 represents a single-dose hyaluronan or derivative (visco-3) intended for intra-articular injection per dose. These products are used in the management of joint conditions to provide joint lubrication and symptom relief, making J7333 relevant for outpatient orthopedic, rheumatology, and pain-management services nationwide. The code matters nationally because it standardizes reporting and billing for a commonly used class of intra-articular biologic agents, affecting coverage decisions, provider documentation, and claims processing.
Key payers covered in this overview include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise summary of what the code denotes, the typical clinical and service settings where the product is administered, and the major payer stakeholders involved. The publication provides benchmarks and coverage context, outlines common billing modifiers and administrative considerations, and situates the code within clinical practice for joint injections. Where specific data elements were not provided in the input, the text notes those fields as unavailable. This summary is intended to support billing staff, practice managers, and policy analysts seeking a clear, national-level briefing on HCPCS Level II code J7333.
Billing Code Overview
HCPCS Level II code J7333 describes a hyaluronan or derivative, visco-3, for intra-articular injection, per dose. This service is a single-dose intra-articular viscosupplementation product intended for injection directly into a joint space to provide lubrication and cushioning.
Service Type: Intra-articular viscosupplementation injection
Typical Site of Service: Outpatient clinic, physician office, or ambulatory surgery center where intra-articular injections are performed
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is a 55–75 year-old ambulatory adult with symptomatic osteoarthritis of the knee who has persistent joint pain and functional limitation despite conservative measures (oral analgesics, physical therapy, activity modification, and intra-articular corticosteroid in some cases). The patient presents to an office-based orthopedic or sports medicine clinic for evaluation. After history and focused knee examination confirming joint line tenderness, crepitus, decreased range of motion, and pain with weight-bearing, the clinician reviews prior imaging (plain radiographs showing joint space narrowing) and documents a discussion of risks, benefits, and alternatives to intra-articular viscosupplementation.
On the day of service the procedure is performed in an outpatient clinic procedure room or ambulatory surgical center under aseptic technique. The hip, shoulder, or other joint may be treated depending on diagnosis, but the knee is the most common. Local anesthetic may be used for comfort. Image guidance (ultrasound or fluoroscopy) may be used depending on clinician preference and anatomy. The billed item J7333 is reported per dose of hyaluronan derivative administered intra-articularly. Post-procedure instructions and follow-up are documented, including expected onset and duration of symptomatic relief and plans for repeat dosing or alternative therapies if needed.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 |